Prenatal transmission of subtype C HIV-1 in Zimbabwe: HIV-1 RNA and DNA in maternal and cord blood

Journal of Acquired Immune Deficiency Syndromes

Volumn 25, Issue 5, 2000, Pages 390-397

  Guevara, Hugo ^a   Johnston, Elizabeth ^b   Zijenah, Lynn ^c   Tobaiwa, Ocean ^c   Mason, Peter ^c   Contag, Christopher ^b   Mahomed, Kassam ^c   Hendry, Michael ^a   Katzenstein, David ^b,c,d  

^a VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cord blood; env diversity; HIV 1; Subtype C; Vertical transmission

Indexed keywords

HETERODUPLEX; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PHYLOGENY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SERODIAGNOSIS; SEROPREVALENCE; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION; VIREMIA; VIRUS ENVELOPE; VIRUS TRANSMISSION; ZIMBABWE;

EID: 0034671488     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200012150-00002     Document Type: Article

References (44)

1. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: Results from 13 perinatal studies
2. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction
3. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire
4. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand
5. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand
6. Serum level of maternal human immunodeficiency virus (HIV) RNA, infant mortality, and vertical transmission of HIV in Zimbabwe
7. Early diagnosis and viral dynamics in HIV-1 infected infants in Thailand using RNA and DNA PCR assays sensitive to Non-B subtypes
8. Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants
9. HIV-1 RNA detection in plasma for the diagnosis of infection in neonates
10. Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal Transmission Collaborative Study
11. Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper
12. The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type I in the era of maternal antiretroviral therapy
13. Clearance of HIV infection in a perinatally infected infant
14. Genetic evaluation of suspected cases of transient HIV-1 infection of infants
15. Features of HIV-1 that could influence maternal-child transmission
16. Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes
17. Inhibition of human immunodeficiency gene amplification by heparin
18. Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma
19. Enzimatic amplification of B-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia
20. Quantitative assessment of HIV-1 DNA load by coamplification of HIV-1 gag and HLA-DQ-α genes
21. Genetic subtyping of Human immunodeficiency virus using heteroduplex mobility assay
22. Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS
23. 1989. PHYLIP-phylogeny inference package (version 3.2)
24. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection
25. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification
26. Quantification of HIV-1 RNA in plasma: Comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test
27. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma
28. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different H1V-1 subtypes
29. Amplicor HIV monitor, NASBA HIV-1 RNA QT and quantiplex HIV RNA version 2.0 viral load assays: A Canadian evaluation
30. Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection
31. Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patients
32. Blood collection on filter paper: A practical approach to sample collection for studies of perinatal HIV transmission
33. Virus levels in untreated African infants infected with human immunodeficiency virus type 1
34. Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens
35. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohort studies
36. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery
37. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
38. Maternal viral load and vertical transmission of HIV-1: An important factor but not the only one
39. Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women
40. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
41. Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina